PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity.

MLA

Fontaine, Shaun D., et al. “PLX038: A PEGylated Prodrug of SN-38 Independent of UGT1A1 Activity.” Cancer Chemotherapy and Pharmacology, vol. 85, no. 1, Jan. 2020, pp. 225–29. EBSCOhost, https://doi.org/10.1007/s00280-019-03987-z.

APA

Fontaine, S. D., Santi, A. D., Reid, R., Smith, P. C., Ashley, G. W., & Santi, D. V. (2020). PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity. Cancer Chemotherapy and Pharmacology, 85(1), 225–229. https://doi.org/10.1007/s00280-019-03987-z

Chicago

Fontaine, Shaun D, Angelo D Santi, Ralph Reid, Philip C Smith, Gary W Ashley, and Daniel V Santi. 2020. “PLX038: A PEGylated Prodrug of SN-38 Independent of UGT1A1 Activity.” Cancer Chemotherapy and Pharmacology 85 (1): 225–29. doi:10.1007/s00280-019-03987-z.